Yew Bio pharm Group Inc   (YEWB)
Other Ticker:  
Price: $0.0010 $0.00 0.000%
Day's High: $0.001 Week Perf: 900 %
Day's Low: $ 0.00 30 Day Perf: -98.87 %
Volume (M): 3 52 Wk High: $ 0.11
Volume (M$): $ 0 52 Wk Avg: $0.03
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 52
 Employees 86
 Revenues (TTM) (Millions $) 29
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Yew Bio Pharm Group Inc
A Nevada corporation; its wholly-owned subsidiaries, Yew Bio-Pharm Holdings Limited (individually, “Yew HK”), a corporation organized under the laws of Hong Kong, and Heilongjiang Jinshangjing Bio-Technology Development Co., Limited (individually, “JSJ”), a corporation organized in the People’s Republic of China, (“China” or the “PRC”); and a deemed variable interest entity, or VIE, Harbin Yew Science and Technology Development Co., Ltd. (individually, “HDS”), a corporation organized in the PRC, and Harbin Yew Food Co. LTD (individually, “HYF”), the subsidiary of HDS, a corporation organized in the PRC.

   Company Address: 9460 Telstar Avenue, El Monte, 91731 CA
   Company Phone Number: 401-9588   Stock Exchange / Ticker: YEWB


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Limoneira Company

The investors are dealing with 2.824%, advance at Limoneira Company all along the second quarter of 2023

For the financial time-frame ending April 30 2023 Limoneira Company slipped into loss of $-0.10 per share compare to $0.08 a year prior and EPS fell from $0.84 per share from the previous financial reporting period. The Revenue grew moderately by 2.824 % to $48.07 million from $46.75 million in the similar financial reporting period a year prior and sequentially revenue improved by 26.83 % from $37.90 million.

Calavo Growers Inc

The Top-line took a nose-dive at CVGW amid the most recent fiscal period

Calavo Growers Inc is currently in a state of turmoil as its business has significantly weakened, leading to a substantial rise in losses for the February to April 30 2023 period. The company's shortfall per share has increased to $-0.23 from $-0.01, indicating a severe blow to its profitability. This is further compounded by the fact that the revenue dropped by a significant -26.169% to $244.69 million from $331.42 million a year ago.
The decline in revenue has come as a significant shock to the industry and is a clear demonstration of the company's inability to keep pace with its competitors. The company's management must take a more proactive approach to regain the lost revenue and position Calavo Growers Inc in a more competitive and desirable position.

Pyxus International Inc

A deficit of $-0.83 per Share at the Agricultural Production company amid the most recent fiscal period

Universal Corporation

It was very robust result by the company over the fourth quarter of 2023 earnings season

Universal Corporation: A Bullish Outlook for Investors
Universal Corporation, the agricultural production company, has reported impressive financial results in its most recent fiscal period. The company posted a revenue surge of 7.266% to $693.98 million as compared to $646.97 million in the previous year. This reflects the company's strong operational capabilities and its ability to capitalize on the growing demand in the agricultural sector. Furthermore, UVV's bottom-line also increased significantly by 108.6% to $2.15 per share.
The company's net income for the fiscal period ending March 31, 2023, rose to $56.668 million, an increase of 67.75% from the previous year. These results speak volumes about the company's ability to create value for its shareholders. Universal Corporation's focus on innovation, sustainability, and operational efficiency has helped it deliver exceptional returns to its shareholders.
Moreover, UVV reported a remarkable EPS increase of 43.23% to $4.97 per share. This is a testament to the company's sound financial management and effective decision-making. Additionally, the company's revenue improved by 22.16%, from $2.10 billion a year ago. The management team at Universal Corporation has been actively pursuing growth opportunities, and these results reflect their passion and hard work.

10x Capital Venture Acquisition Corp Ii

Among many businesses, the VCXAU disclosed as well the first quarter of 2023 numbers

Understanding VCXAU's Recent Financial Performance in the Consumer Non Cyclical Industry
VCXAU, a lesser-known company within the Consumer Non Cyclical industry, recently reported an operating deficit of $-1.217848 million for the first quarter of 2023. This deficit is an improvement when compared to the $-1.906 million deficit recorded in the first quarter of 2022. This financial performance is somewhat expected given that the company is primarily in the research cycle.
Despite the deficit, the positive aspect of this news is that the numbers indicate that the company is making progress in reducing its losses and that it is moving towards fulfilling its potential as a standout bellwether in the Consumer Non Cyclical industry. This improvement in VCXAU's financial performance will be critical in supporting the company?s long journey to become a market leader.


Yew Bio Pharm Group Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071